Home › Pagkabigo ng Puso › Nebraska › Omaha

Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Omaha, NE

Isang pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Omaha. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Nagre-recruitPhase 3

Be Well Clinical Studies, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06935370

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

Nagre-recruit

University of Nebraska Medical Center, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07232030

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Nagre-recruit

University of Nebraska Medical Center, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06526195

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Nagre-recruitObservasyonal na pag-aaral

Omaha, Omaha

Lahat ng edad · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT00271180

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Nagre-recruitPhase 3

University of Nebraska Medical Center, Omaha

Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06736574

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Nagre-recruitPhase 3

Research Site, Omaha

Edad 40 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06677060

NORM-HF Pivotal Study

Nagre-recruit

University of Nebraska Medical Center, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07574593

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Nagre-recruitPhase 3

CON-10018, Omaha, NE, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Nagre-recruitPhase 3

Omaha, NE Investigative Site 10018, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06008197

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Nagre-recruitObservasyonal na pag-aaral

CHI Health Reseach Center, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05489705

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

Nagre-recruit

University of Nebraska Medical Center, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT06895070

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

Nagre-recruitPhase 4

Creighton University Medical Center, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2025 · NCT06964464

Pag-aaral para sa Pagkabigo ng Puso sa ibang lungsod

Iba pang pag-aaral sa Omaha

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.